CMS wants to change Medicare Part D rules to rein in PBMs' controversial practice of clawing back drug payments to pharmacies after point of sale.
In Big Win for Pharmacy Groups, CMS Proposes Significant Changes to Medicare Part D Clawbacks
The Centers for Medicare & Medicaid Services (CMS) yesterday proposed changing Medicare Part D rules to curb plan sponsors and pharmacy benefit managers’ skyrocketing use of direct and indirect renumeration fees (DIR)—PBMs’ controversial practice of clawing back drug payments to pharmacies after the point of sale.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.